Pillstats
Rx only · Injection, Solution · Intramuscular

Fulvestrant

Fulvestrant

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)282357
US makers11 labelers
Packages13
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

9371.9K2.8K3.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.1K
Rx · 2026 Q1
22K
Units dispensed
-17%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it10 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
Avenacy, LLCunknown1SUPPLYING
Dr.Reddy's laboratories Limitedunknown1SUPPLYING
Zydus Lifesciences Limitedunknown1SUPPLYING
BluePoint Laboratoriesunknown1SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown1SUPPLYING
Xiromed, LLC.unknown1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Fresenius Kabi USA, LLCunknown1SUPPLYING
Athenex Pharmaceutical Division, LLC.unknown1EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 15, 2022
    RECALLRecall (Class II): Fulvestrant Injection 250mg/5mL (50 mg/mL), Contains 2 Single-Dose Prefilled Syringes, Rx Only, Product of India, Manuf…

    Failed Impurities/Degradation Specifications — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide.